Maintaining robust calcium levels is fundamental not only for skeletal integrity and dense teeth, but also for vital cardiovascular rhythm, neuromuscular signaling, and muscular contraction. However, ...
Three scientific presentations will highlight new analyses of VOQUEZNA® (vonoprazan) in GERD, including real-world patient characteristics, ...
BridgeBio Pharma (Nasdaq: BBIO) will present data from its Phase 3 CALIBRATE trial of encaleret in autosomal dominant hypocalcemia type 1 (ADH1) at the American Society for Bone and Mineral Research ...
BridgeBio Pharma, Inc. (Nasdaq: BBIO) ('BridgeBio” or the 'Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced ...
The effort will begin with an October 6 YouTube premiere and continue through community conversations and educational programming leading up to World Amyloidosis Day on October 26.